Evidence map›Paper›PMID 29179244›Full record

ReviewRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia2017

Is Ovarian Cancer Prevention Currently Still a recommendation of Our Grandparents?

Millena Prata Jammal, Cid Almeida de Lima, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Millena Prata JammalResearch Institute of Oncology (IPON), Discipline of Gynecology and Obstetrics; Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.
Cid Almeida de LimaResearch Institute of Oncology (IPON), Discipline of Gynecology and Obstetrics; Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.
Eddie Fernando Candido MurtaResearch Institute of Oncology (IPON), Discipline of Gynecology and Obstetrics; Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.
Rosekeila Simões NomeliniResearch Institute of Oncology (IPON), Discipline of Gynecology and Obstetrics; Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brazil.
Universidade Federal do Triângulo Mineiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer is the leading cause of death among gynecologic tumors because in most of the cases (75%), the disease is diagnosed in advanced stages. Screening methods are not available since the disease is rare, and the tested methods, such as ultrasound and CA125, were not able to decrease the mortality rate for this type of cancer. This article discusses the main risk factors for ovarian cancer, and the potential clinical and surgical strategies for the prevention of this disease.

Indexed as

FemaleHumansLife StyleOvarian NeoplasmsRisk Factors

Identifiers

PMID29179244
PMCPMC10309365
OpenAlexW2768285356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.